Australia recognises two more COVID-19 vaccines for international visitors

Covid-19 Coronavirus Vaccine vials in a row macro close up

The Therapeutic Goods Administration (TGA) has announced it will recognise two more COVID-19 vaccines that are not registered in Australia but used widely internationally.

The TGA has determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be recognised for the purpose of establishing a traveller’s vaccination status.

This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV.

In recent weeks, the TGA said it has “obtained additional information demonstrating these vaccines provide protection and potentially reduce the likelihood that an incoming traveller would transmit COVID-19 infection to others while in Australia or become acutely unwell due to COVID-19”.

“The supporting information has been provided to the TGA from the vaccine sponsor and/or the World Health Organisation,” it said in a statement.

Recognition of Covaxin and BBIBP-CorV, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca, India), means many citizens of China and India, as well as other countries in the region where these vaccines have been widely deployed, will now be considered fully vaccinated on entry to Australia.

The TGA’s decision is a big positive for the return of international students and the travel of skilled and unskilled workers to Australia, and comes not long after Prime Minister Scott Morrison said he “fully anticipates” the return of double-vaxxed international tourists by the end of the year.

In addition, with input from the TGA, the Australian Technical Advisory Group on Immunisation (ATAGI) has determined that those who have received two doses of a TGA-approved or recognised vaccine at least 14 days apart are regarded as fully vaccinated from seven days after the second dose (with the exception of Janssen vaccine, where they are regarded as fully vaccinated seven days after the single dose).

This includes homologous (two doses of the same vaccine) and heterologous (two doses of two different TGA-approved or recognised vaccines) schedules.

As of yesterday, vaccinated Aussies and permanent residents aged 12 and over are allowed to head overseas without the need to seek a travel exemption.


Featured image source: iStock/MarsBars

Latest News

  • Destinations
  • News

APT Launches 2025 Asia Adventures

APT has launched its Asia Adventures for 2025, including new luxury holidays in India, Sri Lanka and Japan. Five new tours lead guests to the highlights of India, including a seven-night cruise along the rarely travelled Lower Ganges aboard the Ganges Voyager. Further south, Sri Lanka’s greatest destinations are revealed on a new 15-day Land […]

  • Cruise
  • Luxury
  • News

Seabourn announces Western Kimberley Traditional Owners as Godparents of Seabourn Pursuit

Seabourn has named Western Kimberley Traditional Owners, the Wunambal Gaambera, as Godparents of the ultra-luxury purpose-built Seabourn Pursuit. It is the first cruise line to appoint Traditional Owners as godparents of a ship. Seabourn Pursuit embarks on its inaugural season in the Kimberley region this June. The naming ceremony will take place on Seabourn Pursuit’s […]

  • Luxury

Malolo Island Resort opens brand new Spa

Fiji’s Malolo Island has added another string to its bow – opening its $1.3 million day spa on Thursday, 18th April 2024. (Lead Image: matriarch Rosie Whitton with spa staff) Located at the edge of the resort’s luscious patch of tropical rainforest, the new “Leilani’s Spa” adds another level of elevated experiences to Malolo’s already […]